Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study
Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Aug 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study," is investigating whether people can accurately collect skin samples themselves to help diagnose scabies, a skin condition caused by tiny mites. The researchers want to see if these self-collected samples are just as good as those collected by healthcare professionals. They will also compare two methods of testing the samples – one using a technique called polymerase chain reaction (PCR) and the other using a microscope.
To be eligible for this study, participants must be at least 18 years old and have either suspected, clinical, or confirmed scabies. However, individuals who have been treated for scabies in the last six weeks or have specific health issues may not qualify. If you decide to participate, you will be asked to provide a sample of your skin, and the study aims to make the diagnosis process easier and more accessible for everyone. This trial is currently recruiting participants, and your involvement could help improve future scabies diagnosis methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Have either suspected scabies, clinical scabies or confirmed scabies (see table 1)
- • Providing informed consent (IC)
- Exclusion Criteria:
- • Individuals not speaking or understanding the Dutch or English language.
- • Individuals who have been diagnosed with scabies in the last six weeks and had started treatment.
- • Individuals who have used ivermectin for other diagnoses than scabies in the last six weeks.
- • Individuals younger than 18 years.
- • Individuals with immunosuppressive conditions (see appendix A).
- • Any other condition, finding or situation which, in the opinion of the investigator, may significantly increase the risk to the individual because of participation in the study, affect the ability of the individual to participate in the study or impair interpretation of the study data.
About Radboud University Medical Center
Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nijmegen, Gelderland, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported